|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls000855104 |
| 003 |
SK-MaSNL |
| 005 |
20260304122848.0 |
| 008 |
250429c2003 xo 0 slo |
| 015 |
|
|
|a SNBRB2003/12-35506
|
| 035 |
|
|
|a CLN000206759
|
| 035 |
|
|
|a urn:nbn:sk:snk-ab6z9p
|
| 035 |
|
|
|a (uuid)b9ebff9a-56f2-47cc-bb7a-c5bbdf6e159f
|
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-a06c9l
|
| 035 |
|
|
|a (sysno)vtls000855104
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a eng
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 616.33-002.44-006:616-097
|2 1997
|
| 100 |
1 |
|
|a Atalay, C.
|4 aut
|9 1248349
|
| 245 |
1 |
0 |
|a Serum Helicobacter pylori IgG and IgA levels in patients with gastric cancer
|c C. Atalay, G. Atalay, M. Altinok
|
| 300 |
|
|
|b Tab.
|
| 504 |
|
|
|a Res. angl.
|
| 504 |
|
|
|a Bibliogr. odkazy
|
| 650 |
0 |
7 |
|a Helicobacter pylori
|x patogenita
|2 MESH
|9 851830
|
| 650 |
0 |
7 |
|a nádory žalúdka
|x komplikácie
|x imunológia
|x patológia
|2 MESH
|9 1430415
|
| 650 |
0 |
7 |
|a imunoglobulín G
|x analýza
|x použitie diagnostické
|2 MESH
|9 1428633
|
| 650 |
0 |
7 |
|a imunoglobulín A
|x analýza
|x použitie diagnostické
|2 MESH
|9 1428584
|
| 655 |
|
7 |
|a články z novín a časopisov
|2 snkbucl
|9 267496
|
| 700 |
1 |
|
|a Atalay, G.
|4 aut
|9 1248350
|
| 700 |
1 |
|
|a Altinok, M.
|4 aut
|9 1248351
|
| 773 |
0 |
|
|t Neoplasma
|g Vol. 50, no. 3 (2003), s. 185-190
|x 0028-2685
|
| 850 |
|
|
|a Slovenská národná knižnica
|
| 852 |
|
|
|a Slovenská národná knižnica
|
| 958 |
|
|
|a article27
|
| 958 |
|
|
|a NB
|
| 958 |
|
|
|a MI
|
| 958 |
|
|
|a OND
|
| 958 |
|
|
|a EUIPO
|
| 992 |
|
|
|a RBX
|
| 999 |
|
|
|c 2888889
|d 2890819
|
